VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
PG
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
PGThe Procter & Gamble Company
$159.31$371.1B
Overview & Tools
OverviewChart Terminal ↗AnalysisVisualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksPGFinancials

The Procter & Gamble Company (PG) Income Statement

30Y historyFree accessUpdated daily

Revenue growth has been stable at ~1.5% annually, but gross margin contracted 390 basis points from peak to 48.5% in 2026Q4, driving operating margin down to 18.6% from 26.7% a year earlier.

Income StatementBalance SheetCash FlowRatios

PG Income Statement

Annual statement

PG Income Statement

The Procter & Gamble Company (PG) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricJun'26Jun'25Jun'24Jun'23Jun'22Jun'21Jun'20Jun'19Jun'18Jun'17Jun'16Jun'15Jun'14Jun'13Jun'12Jun'11Jun'10Jun'09Jun'08Jun'07Jun'06Jun'05Jun'04Jun'03Jun'02Jun'01Jun'00Jun'99Jun'98Jun'97
Sales/Revenue87.03B84.28B84.04B82.01B80.19B76.12B70.95B67.68B66.83B65.06B65.3B70.75B74.4B80.12B82.01B81.1B77.57B76.69B81.75B76.48B68.22B56.74B51.41B43.38B40.24B39.24B39.95B38.13B37.15B35.76B
Revenue Growth %3.26%0.29%2.48%2.27%5.35%7.28%4.83%1.27%2.73%-0.37%-7.7%-4.91%-7.13%-2.3%1.11%4.56%1.14%-6.18%6.89%12.1%20.23%10.38%18.51%7.8%2.53%-1.77%4.79%2.61%3.89%1.36%
Cost of Goods Sold43.36B41.16B40.85B42.76B42.16B37.11B35.25B34.77B34.43B32.64B32.91B37.06B39.03B39.99B41.41B39.86B37.04B38.69B39.54B36.69B33.13B27.87B25.14B22.14B20.99B22.1B21.51B21.03B21.06B20.51B
COGS % of Revenue49.82%48.84%48.61%52.14%52.57%48.75%49.68%51.37%51.52%50.17%50.4%52.38%52.46%49.92%50.5%49.15%47.75%50.45%48.36%47.97%48.55%49.12%48.91%51.04%52.16%56.32%53.85%55.15%56.69%57.35%
Gross Profit43.67B43.12B43.19B39.25B38.03B39.01B35.7B32.92B32.4B32.42B32.39B33.69B35.37B40.13B40.59B41.24B40.52B38B42.21B39.79B35.1B28.87B26.26B21.24B19.25B17.14B18.44B17.1B16.09B15.25B
Gross Margin %50.18%51.16%51.39%47.86%47.43%51.25%50.32%48.63%48.48%49.83%49.6%47.62%47.54%50.08%49.5%50.85%52.25%49.55%51.64%52.03%51.45%50.88%51.09%48.96%47.84%43.68%46.15%44.85%43.31%42.65%
Gross Profit Growth %1.27%-0.16%10.05%3.2%-2.51%9.27%8.46%1.59%-0.06%0.09%-3.87%-4.74%-11.85%-1.16%-1.58%1.78%6.63%-9.97%6.09%13.37%21.57%9.92%23.68%10.32%12.29%-7.02%7.83%6.26%5.48%5.04%
Operating Expenses23.92B22.67B24.65B21.11B20.22B21.02B19.99B27.43B19.04B18.65B18.95B22.64B21.46B26.31B27.56B25.75B24.79B22.63B25.29B24.34B21.85B18.4B16.88B13.38B12.57B12.41B12.48B10.85B10.04B9.77B
OpEx % of Revenue27.49%26.9%29.33%25.74%25.21%27.62%28.18%40.53%28.48%28.67%29.02%32.01%28.84%32.84%33.61%31.75%31.96%29.51%30.94%31.83%32.02%32.43%32.84%30.85%31.24%31.61%31.25%28.45%27.01%27.31%
Selling, General & Admin23.92B22.67B23.3B21.11B20.22B21.02B19.99B19.08B19.04B18.65B18.95B20.62B21.46B26B25.98B25.75B24.79B22.63B25.57B24.34B21.85B18.4B16.88B13.38B12.57B12.41B12.48B10.85B10.04B9.77B
SG&A % of Revenue27.49%26.9%27.73%25.74%25.21%27.62%28.18%28.2%28.48%28.67%29.02%29.14%28.84%32.45%31.69%31.75%31.96%29.51%31.29%31.83%32.02%32.43%32.84%30.85%31.24%31.61%31.25%28.45%27.01%27.31%
Research & Development000000000000000000000000000000
R&D % of Revenue------------------------------
Other Operating Expenses001.34B00008.35B0002.03B0308M1.58B000000000000000
Operating Income19.75B20.45B18.55B18.13B17.81B17.99B15.71B5.49B13.36B13.77B13.44B11.05B13.91B13.82B13.04B15.49B15.73B16.66B16.92B15.45B13.25B10.47B9.38B7.85B6.68B4.74B5.95B6.25B6.05B5.49B
Operating Margin %22.69%24.26%22.07%22.11%22.21%23.63%22.14%8.11%19.99%21.16%20.58%15.62%18.7%17.25%15.9%19.11%20.28%21.73%20.7%20.2%19.42%18.45%18.25%18.1%16.6%12.07%14.9%16.4%16.3%15.35%
Operating Income Growth %-3.44%10.28%2.27%1.8%-0.96%14.52%186.24%-58.94%-2.93%2.42%21.65%-20.57%0.67%6%-15.88%-1.51%-5.58%-1.54%9.53%16.61%26.55%11.59%19.47%17.6%41.01%-20.46%-4.78%3.27%10.33%13.98%
EBITDA21.25B23.3B21.44B20.85B20.62B20.72B18.72B8.31B16.2B16.59B16.52B14.18B17.05B16.8B16.24B18.33B18.84B19.74B20.09B18.58B15.88B12.35B11.12B9.56B8.37B7.01B8.14B8.4B7.65B6.97B
EBITDA Margin %24.42%27.64%25.51%25.42%25.71%27.22%26.38%12.28%24.24%25.49%25.3%20.05%22.92%20.97%19.8%22.6%24.29%25.74%24.57%24.3%23.27%21.77%21.62%22.03%20.8%17.85%20.39%22.04%20.6%19.5%
EBITDA Growth %-8.77%8.66%2.84%1.11%-0.49%10.7%125.23%-48.69%-2.35%0.41%16.47%-16.82%1.5%3.45%-11.42%-2.69%-4.58%-1.72%8.12%17.03%28.52%11.14%16.31%14.16%19.47%-13.97%-3.05%9.77%9.72%12.99%
D&A (Non-Cash Add-back)02.85B2.9B2.71B2.81B2.73B3.01B2.82B2.83B2.82B3.08B3.13B3.14B2.98B3.2B2.84B3.11B3.08B3.17B3.13B2.63B1.88B1.73B1.7B1.69B2.27B2.19B2.15B1.6B1.49B
EBIT21.25B21.07B19.69B19.11B18.43B18.12B16.3B6.58B13.83B13.72B13.95B11.64B14.22B14.85B13.3B15.83B15.81B15.77B17.1B15.45B13.25B10.47B9.38B7.85B6.68B4.74B5.95B6.25B6.05B5.49B
Net Interest Income-447M-438M-452M-449M-388M-457M-310M-289M-259M-294M-397M-477M-610M-579M-692M-769M-946M-1.36B-1.47B00000000000
Interest Income430M469M473M307M51M45M155M220M247M171M182M149M99M87M77M62M00000000000000
Interest Expense877M907M925M756M439M502M465M509M506M465M579M626M709M667M769M831M946M1.36B1.47B00000000000
Other Income/Expense629M-284M216M219M182M-371M128M582M-37M-509M-72M-37M-401M362M-507M-498M-864M-2.25B-1.29B-740M-836M-488M-477M-323M-295M-120M-418M-415M-347M-239M
Pretax Income20.38B20.17B18.76B18.35B18B17.61B15.83B6.07B13.33B13.26B13.37B11.01B13.51B14.18B12.53B15B14.87B14.41B15.63B14.71B12.41B9.98B8.9B7.53B6.38B4.62B5.54B5.84B5.71B5.25B
Pretax Margin %23.41%23.93%22.32%22.38%22.44%23.14%22.32%8.97%19.94%20.38%20.47%15.56%18.16%17.7%15.28%18.49%19.17%18.79%19.12%19.23%18.2%17.59%17.32%17.36%15.86%11.76%13.86%15.31%15.36%14.68%
Income Tax4.23B4.1B3.79B3.62B3.2B3.26B2.73B2.1B3.46B3.06B3.34B2.73B2.85B3.23B3.38B3.3B4.02B3.73B3.83B4.37B3.73B3.06B2.75B2.34B2.03B1.69B1.99B2.08B1.93B1.83B
Effective Tax Rate %20.77%20.34%20.19%19.7%17.79%18.52%17.25%34.65%26%23.1%25%24.75%21.1%22.75%26.96%22%27.02%25.9%24.53%29.71%30.04%30.64%30.87%31.13%31.82%36.7%36.02%35.54%33.78%34.94%
Net Income16.05B15.97B14.88B14.65B14.74B14.31B13.03B3.9B9.75B15.33B10.51B7.04B11.64B11.31B10.76B11.8B12.74B11.43B12.07B10.34B8.68B6.92B6.16B5.19B4.35B2.92B3.54B3.76B3.78B3.42B
Net Margin %18.44%18.95%17.7%17.87%18.38%18.79%18.36%5.76%14.59%23.56%16.09%9.95%15.65%14.12%13.12%14.55%16.42%14.9%14.77%13.52%12.73%12.2%11.97%11.96%10.82%7.45%8.87%9.87%10.17%9.55%
Net Income Growth %0.45%7.36%1.54%-0.6%3.05%9.82%234.28%-60.03%-36.38%45.85%49.35%-39.57%2.93%5.17%-8.82%-7.37%11.47%-5.38%16.78%19.07%25.44%12.46%18.7%19.16%48.94%-17.5%-5.87%-0.45%10.69%12.11%
Net Income (Continuing)16.14B16.07B14.97B14.74B14.79B14.35B13.1B3.97B9.86B10.19B10.03B8.29B10.66B10.95B9.15B11.7B10.85B10.68B11.8B10.34B8.68B6.92B6.16B5.19B4.35B2.92B3.54B3.76B3.78B3.42B
Discontinued Operations0000000005.22B577M-1.14B1.13B101M1.75B229M2B2.76B277M00000000000
Minority Interest0272M272M288M265M276M357M385M590M594M642M631M762M645M596M361M324M283M000000000000
EPS (Diluted)6.626.516.025.905.815.504.961.433.675.593.692.444.013.863.663.934.114.263.643.042.642.532.201.701.551.031.301.371.181.10
EPS Growth %1.69%8.14%2.03%1.55%5.64%10.89%246.85%-61.04%-34.35%51.49%51.23%-39.15%3.89%5.46%-6.87%-4.38%-3.52%17.03%19.74%15.15%4.35%15%29.41%9.68%50.49%-20.77%-5.11%16.1%7.27%12.24%
EPS (Basic)6.756.676.186.076.005.695.131.453.755.803.802.504.194.043.824.124.324.493.863.222.792.702.341.801.631.081.361.431.251.18
Diluted Shares Outstanding2.42B2.45B2.47B2.48B2.54B2.6B2.63B2.54B2.66B2.74B2.84B2.88B2.9B2.93B2.94B3B3.1B3.15B3.32B3.4B3.29B2.74B2.79B2.8B2.81B2.81B2.72B2.75B3.12B3.01B
Basic Shares Outstanding2.42B2.45B2.36B2.37B2.46B2.51B2.54B2.5B2.53B2.6B2.77B2.81B2.78B2.8B2.82B2.8B2.95B2.99B3.08B3.16B3.05B2.52B2.58B2.59B2.59B2.6B2.61B2.63B2.94B2.81B
Dividend Payout Ratio63.77%61.8%62.58%61.41%59.49%57.76%59.79%192.4%74.97%47.21%70.77%103.57%59.36%57.63%57.08%48.89%42.85%44.15%37.09%39.15%40.94%37.48%41.24%43.31%48.14%66.5%50.71%43.21%38.68%38.92%

Key Metrics

Growth RegimeStable
ProfitabilityStable
Balance SheetAdequate
Cash FlowStable
Top Statement Risk

Margin compression from cost inflation

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q4)

Stable Top-Line, Underlying Volume Concerns

Revenue growth averaged roughly 1.5% over the past year, with the latest quarter showing 1.5% growth, suggesting a stable but sluggish trajectory. According to recent financial statements, PG's revenue growth remains muted, indicating limited pricing power or volume gains.

The 10-quarter revenue trend shows a narrow band between $19.8B and $22.4B, with no quarter exceeding 7.4% growth. The most recent quarter (2026Q4) grew 1.5% YoY, consistent with the prior year's average, implying that the company is maintaining share but not accelerating. The lack of meaningful acceleration suggests that volume growth is offset by price declines or mix shifts, and the company may be relying on cost savings to protect margins rather than driving top-line expansion.

Gross Margin Resilience Amid Cost Pressures

Gross margin has remained relatively stable around 50%, with the latest quarter at 48.5%, down from 51.4% in 2026Q1. As reported in PG's income statements, gross margin has contracted by roughly 300 basis points from peak, suggesting input cost inflation is eroding pricing power.

The gross margin trend shows a peak of 52.4% in 2025Q2, followed by a gradual decline to 48.5% in 2026Q4. This 390 basis point contraction indicates that commodity costs (pulp, resin, chemicals) are rising faster than PG's ability to raise prices, or that trade promotions are increasing. The company's gross margin remains above peers like KMB (35.6%) but below CL (60.1%), reflecting its premium positioning but also its exposure to commodity inputs. Investors should monitor whether PG can restore margins through productivity programs or further price increases.

Operating Leverage Fading as Costs Outpace Sales

Operating margin has declined from 26.7% in 2025Q1 to 18.6% in 2026Q4, a drop of over 800 basis points. Based on reported figures, SG&A has remained relatively flat, but gross margin compression has directly hit operating income, indicating that PG is losing operating leverage.

The operating margin trend shows a clear deterioration, with the latest quarter at 18.6%, the lowest in the 10-quarter period. SG&A as a percentage of revenue has actually decreased slightly (from 29.5% in 2025Q1 to 29.7% in 2026Q4), but the gross margin decline has overwhelmed any SG&A efficiency. This suggests that PG's fixed-cost base is not scaling with revenue, and the company is unable to offset input cost inflation with volume growth. The operating income decline from $5.9B in 2026Q1 to $4.0B in 2026Q4 highlights the severity of the margin squeeze.

EPS Volatility Raises Quality Questions

EPS has swung from $1.95 in 2026Q1 to $1.26 in 2026Q4, a 35% decline, while net income fell from $4.8B to $3.0B. According to the income statement data, the latest quarter's EPS miss of $0.46 versus consensus suggests potential one-time charges or tax anomalies that warrant scrutiny.

The earnings quality appears strained, as the EPS decline is much steeper than the revenue decline, indicating that the bottom line is more sensitive to cost and tax items. The effective tax rate appears to have fluctuated, with net margin dropping from 21.2% in 2026Q1 to 14.1% in 2026Q4, a 710 basis point swing. Stock-based compensation has been relatively stable at around $130M per quarter, so it is not the primary driver. The large EPS miss in the latest quarter, despite management maintaining guidance, suggests that the shortfall may be due to non-operating items or a conservative outlook, but the magnitude of the miss raises concerns about the predictability of earnings.

COGS Inflation Outpacing Revenue Growth

COGS has risen from $9.9B in 2024Q3 to $10.9B in 2026Q4, a 10% increase, while revenue grew only 5% over the same period. As reported in PG's financial statements, the cost of goods sold is growing faster than sales, indicating that input costs are a primary margin headwind.

The cost structure is heavily weighted toward COGS, which represents roughly 51% of revenue. The COGS increase of $1.0B over the period, while revenue increased only $1.0B, implies that PG is absorbing cost inflation without passing it fully to consumers. SG&A has remained relatively flat, suggesting that management is controlling overhead, but the COGS pressure is the main driver of margin compression. The company's productivity programs may be offsetting some of these costs, but the data suggests that they are not sufficient to maintain historical margins.

2026Q4 Marks a Margin Inflection Point

The most significant inflection occurred in 2026Q4, where gross margin fell to 48.5% and operating margin to 18.6%, the lowest levels in the 10-quarter period. Based on the income statement data, this quarter represents a clear deterioration from the prior year's stability, suggesting a structural shift in cost dynamics.

The 2026Q4 results show a sharp drop in profitability across all margin lines, with net margin at 14.1%, down from 18.7% in the prior quarter. This inflection appears to be driven by a combination of rising COGS and a slight increase in SG&A, while revenue growth remained modest. The EPS miss of $0.46 versus consensus indicates that the market did not anticipate this margin compression, and the maintained guidance suggests management believes it is temporary. However, the persistence of cost pressures across multiple quarters may indicate a more lasting impact on PG's earnings power.

Margin Compression Could Persist

The bear case centers on PG's inability to pass on cost inflation, as evidenced by the 390 basis point gross margin decline from peak. According to recent income statements, the company's pricing power may be weakening, and volume growth remains elusive, suggesting that margins could stay depressed.

Short-sellers would highlight that PG's revenue growth has been stagnant, while COGS has risen, indicating that the company is losing pricing power to private labels and discounters. The gross margin of 48.5% is still high, but the trend is concerning, and if commodity costs remain elevated, PG may need to increase prices further, risking volume loss. The operating margin decline to 18.6% is below the peer average of CL (21.3%), and if this persists, PG's premium valuation could be challenged. The maintained guidance may be overly optimistic, and investors should monitor whether the company can restore margins through cost savings or if the current level is the new normal.

PG — Frequently Asked Questions

Quick answers to the most common questions about buying PG stock.

What was The Procter & Gamble Company's (PG) revenue in 2026?

For fiscal year 2026, The Procter & Gamble Company (PG) reported total revenue of $87.03B. This represents a 143.4% increase compared to $35.76B in 1997.

Is The Procter & Gamble Company (PG) profitable?

The Procter & Gamble Company (PG) is profitable, generating $16.05B in net income for the fiscal year ending 2026 with a net profit margin of 18.4%.

What is The Procter & Gamble Company's operating profit margin?

The Procter & Gamble Company (PG) reported an operating income of $19.75B, resulting in an operating profit margin of 22.7%. This margin reflects the operational efficiency of the business before interest and taxes.

What is The Procter & Gamble Company's gross profit and gross margin?

The Procter & Gamble Company (PG) generated $43.67B in gross profit for the year, representing a gross profit margin of 50.2%. This demonstrates the company's core pricing power and production efficiency.